Chihiro Kosugi

Dr. Chihiro Kosugi

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2005 in Surgery
Verified
Journal Article
Closed access
CKChihiro Kosugi
Chihiro Kosugi
NSNorio Saito
Norio Saito
YKYoshitaka Kimata
Yoshitaka Kimata
MOMasato Ono
Masato Ono
MSMasanori Sugito
Masanori Sugito
MMMasaru Miyazaki
Masaru Miyazaki

17 December 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
MMMikito Mori
Mikito Mori
KSKiyohiko Shuto
Kiyohiko Shuto
CKChihiro Kosugi
Chihiro Kosugi
KNKazuo Narushima
Kazuo Narushima
HHHideki Hayashi
Hideki Hayashi
KKKeiji Koda
Keiji Koda
The neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) are associated with poor prognoses in patients with gastric cancer; however, few studies have focused on the dynamic changes in these ratios during the treatment of patients with gastric cancer. Here, we assessed the clinical utility of changes in these ratios as prognostic indicators in patients with stage II or III gastric cancer who received adjuvant chemotherapy. We retrospectively reviewed 100 patients who received S-1 adjuvant chemotherapy at ≥70% of the relative dose intensity, and their NLRs and PLRs were evaluated at different times: prior to gastrectomy and upon commencement and termination of adjuvant chemotherapy. To assure the clinical utility of the changes in NLR and PLR as prognostic indicators, other clinical factors were assessed as well. Disease recurred in 35 patients as follows: lymph node metastasis (17 patients, 17.0%), peritoneal metastasis (12 patients, 12.0%), and hematogenous metastasis (6 patients, 6.0%); 24 patients died. An increase in the NLR during adjuvant chemotherapy with S-1 was identified as an independent indicator associated with overall survival (hazard ratio [HR] 6.736, 95% confidence interval [CI] 2.420–18.748; P < 0.001), and relapse-free survival (HR 5.309, 95% CI 2.585–10.901; P < 0.001). An increase in the NLR during S-1 adjuvant chemotherapy may be a useful prognostic indicator in patients with stage II or III gastric cancer.

21 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
KSKiyohiko Shuto
Kiyohiko Shuto
YNYoshihiro Nabeya
Yoshihiro Nabeya
MMMikito Mori
Mikito Mori
MYMasato Yamazaki
Masato Yamazaki
CKChihiro Kosugi
Chihiro Kosugi
KKKeiji Koda
Keiji Koda
Background: Postoperative changes in body composition (BC) have not been clearly defined. The aim of this study was to clarify the impact of postoperative comprehensive changes in BC on long-term prognosis in gastric cancer (GC) patients. Methods: A total of 366 GC patients who underwent radical gastrectomy were included. Postoperative changes in skeletal muscle volume, body fat volume, and skeletal muscle density were investigated at six months postoperatively using computed tomography and evaluated their association with long-term survival. Results: Patients with decreased muscle volume, decreased fat volume, and increased muscle density had a poor prognosis, respectively. When the risk scores based on these three BC parameters were applied, patients were classified from score 0 to 4, with survival rate declining as the scores improved: score 0, interim 5-year overall survival 94%; score 1, 82%; score 2, 73%; score 3, 56%; and score 4, 20%. BC change (score > 2) was an independent poor prognosticator (HR, 3.086; p < 0.001). Preoperative myosteatosis, high Charlson comorbidity, and total gastrectomy were identified as significant independent risk factors for BC change. Conclusions: Each of postoperative skeletal muscle loss, body fat loss, and muscle hyperdensity negatively affected prognosis of GC patients after surgery, and the BC risk scoring assessment well predicted the prognosis of postoperative patients with GC.

27 February 2018 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
CKChihiro Kosugi
Chihiro Kosugi
KKKeiji Koda
Keiji Koda
KIKeiichiro Ishibashi
Keiichiro Ishibashi
KYKazuhiko Yoshimatsu
Kazuhiko Yoshimatsu
STSoichi Tanaka
Soichi Tanaka
HIHideyuki Ishida
Hideyuki Ishida

21 May 2009
Verified
Journal Article
Closed access
KSKazuhiro Seike
Kazuhiro Seike
KKKeiji Koda
Keiji Koda
KOKenji Oda
Kenji Oda
CKChihiro Kosugi
Chihiro Kosugi
KSKimio Shimizu
Kimio Shimizu
Masaru MiyazakiMasaru Miyazaki
Masaru Miyazaki

14 March 2024 in Annals of Surgery Open
Verified
Journal Article
Open access
CKChihiro Kosugi
Chihiro Kosugi
KKKeiji Koda
Keiji Koda
HSHiroaki Shimizu
Hiroaki Shimizu
MYMasato Yamazaki
Masato Yamazaki
KSKiyohiko Shuto
Kiyohiko Shuto
HKHideyuki Kuboki
Hideyuki Kuboki
Objective: To determine whether Aquacel Ag Hydrofiber dressings containing ionic silver are superior to film dressings for preventing superficial surgical site infections (SSI) in patients undergoing elective gastrointestinal surgery. Background: Multiple clinical trials have assessed the effectiveness of silver-containing wound dressings; however, systematic reviews failed to find any advantages of these dressings and concluded that there was insufficient evidence to indicate that they prevented wound infections. This study aimed to evaluate the efficacy of Aquacel Ag Hydrofiber dressings for preventing superficial SSIs in patients undergoing gastrointestinal surgery. Methods: Patients undergoing elective gastrointestinal surgery were randomly assigned to receive either Aquacel Ag Hydrofiber (study group) or film dressings (control group). The primary end point was superficial SSI within 30 days after surgery (UMIN Clinical Trials Registry ID: 000043081). Results: A total of 865 patients (427 study group, 438 control group) were qualified for primary end-point analysis. The overall rate of superficial SSIs was significantly lower in the study group than in the control group (6.8% vs 11.4%, P = 0.019). There was no significant difference in superficial SSI rates between the groups in patients undergoing upper gastrointestinal surgery; however, the rate was significantly lower in the study group in patients undergoing lower gastrointestinal surgery (P = 0.042). Multivariate analysis identified Aquacel Ag Hydrofiber dressings as an independent factor for reducing superficial SSIs (odds ratio, 0.602; 95% confidence interval, 0.367–0.986; P = 0.044). Conclusions: Aquacel Ag Hydrofiber dressings can reduce superficial SSIs compared to film dressings in patients undergoing elective gastrointestinal surgery, especially lower gastrointestinal surgery.